| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.06 |